Vimarsana
Biggest News Aggregation in the World

Master Files News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Master Files. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Master Files Today - Breaking & Trending Today

ODSP's Welch: NDIN 'guidances are not enforceable' - Vimarsana News

ODSP's Welch: NDIN 'guidances are not enforceable'

FDA’s director of the Office of Dietary Supplement Programs (ODSP), Cara Welch, PhD, stopped by SupplySide East to present an overview of the agency’s FY23 activities related to dietary supplements and FY24 plans as well as an update on the pending Human Foods Program reorganization. She sat down with NutraIngredients-USA to discuss these topics and more.

FDA Roundup: April 5, 2024 - Vimarsana News

FDA Roundup: April 5, 2024

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an...

Draft Guidance for Industry: New Dietary Ingredient Notification Master Files for Dietary Supplements - Vimarsana News

Draft Guidance for Industry: New Dietary Ingredient Notification Master Files for Dietary Supplements

This guidance provides recommendations to industry on Master Files for new dietary ingredient notifications (NDINs).

Source: fda.gov
Dr. Reddy's Q3 & 9M FY24 Financial Results -January 31, 2024 at 09:45 am EST - Vimarsana News

Dr. Reddy's Q3 & 9M FY24 Financial Results -January 31, 2024 at 09:45 am EST

Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the quarter and nine months ended December 31, 2023. The information mentioned in this release is based on...

FDA Ushers in New Program for Drug Products Manufactured Using Innovative Manufacturing Technologies | King & Spalding - Vimarsana News

FDA Ushers in New Program for Drug Products Manufactured Using Innovative Manufacturing Technologies | King & Spalding

Under Section 3213 of Food and Drug Omnibus Reform Act, the U.S. Food & Drug Administration (“FDA” or the “Agency”) is required to establish the Advanced Manufacturing Technologies...